These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12002517)

  • 41. Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein G alpha qi5.
    Camarda V; Fischetti C; Anzellotti N; Molinari P; Ambrosio C; Kostenis E; Regoli D; Trapella C; Guerrini R; Severo S; Calo G
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jun; 379(6):599-607. PubMed ID: 19183962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations.
    Ferrari F; Cerlesi MC; Malfacini D; Asth L; Gavioli EC; Journigan BV; Kamakolanu UG; Meyer ME; Yasuda D; Polgar WE; Rizzi A; Guerrini R; Ruzza C; Zaveri NT; Calo G
    Eur J Pharmacol; 2016 Dec; 793():1-13. PubMed ID: 27780725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
    Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
    J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510).
    Varty GB; Lu SX; Morgan CA; Cohen-Williams ME; Hodgson RA; Smith-Torhan A; Zhang H; Fawzi AB; Graziano MP; Ho GD; Matasi J; Tulshian D; Coffin VL; Carey GJ
    J Pharmacol Exp Ther; 2008 Aug; 326(2):672-82. PubMed ID: 18492950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5.
    Guerrini R; Marzola E; Trapella C; Pacifico S; Cerlesi MC; Malfacini D; Ferrari F; Bird MF; Lambert DG; Salvadori S; Calo G
    Bioorg Med Chem; 2015 Apr; 23(7):1515-20. PubMed ID: 25716007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
    Narita M; Mizoguchi H; Oji DE; Dun NJ; Hwang BH; Nagase H; Tseng LF
    Br J Pharmacol; 1999 Nov; 128(6):1300-6. PubMed ID: 10578145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.
    Berger H; Bigoni R; Albrecht E; Richter RM; Krause E; Bienert M; Calo' G
    Peptides; 2000 Jul; 21(7):1131-9. PubMed ID: 10998548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors.
    Bigoni R; Caò G; Rizzi A; Okawa H; Regoli D; Smart D; Lambert DG
    Can J Physiol Pharmacol; 2002 May; 80(5):407-12. PubMed ID: 12056546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor.
    Gunduz O; Sipos F; Spagnolo B; Kocsis L; Magyar A; Orosz G; Borsodi A; Calò G; Benyhe S
    Neurosignals; 2006-2007; 15(2):91-101. PubMed ID: 16874009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of rat olfactory bulb.
    Onali P; Olianas MC
    Br J Pharmacol; 2004 Nov; 143(5):638-48. PubMed ID: 15451772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY; Trapella C; Chiou LC
    Eur J Pharmacol; 2009 Mar; 606(1-3):84-9. PubMed ID: 19374842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine.
    Reiss D; Wichmann J; Tekeshima H; Kieffer BL; Ouagazzal AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):141-8. PubMed ID: 18031727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat.
    Obara I; Przewlocki R; Przewlocka B
    Pain; 2005 Jul; 116(1-2):17-25. PubMed ID: 15927383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
    Marti M; Stocchi S; Paganini F; Mela F; De Risi C; Calo' G; Guerrini R; Barnes TA; Lambert DG; Beani L; Bianchi C; Morari M
    Br J Pharmacol; 2003 Jan; 138(1):91-8. PubMed ID: 12522077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.
    Judd AK; Kaushanskaya A; Tuttle DJ; Sanchez A; Khroyan T; Polgar W; Toll L
    J Pept Res; 2003 Nov; 62(5):191-8. PubMed ID: 14531842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.
    Thompson AA; Liu W; Chun E; Katritch V; Wu H; Vardy E; Huang XP; Trapella C; Guerrini R; Calo G; Roth BL; Cherezov V; Stevens RC
    Nature; 2012 May; 485(7398):395-9. PubMed ID: 22596163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
    Bigoni R; Rizzi A; Rizzi D; Becker JA; Kieffer BL; Simonin F; Regoli D; Calo G
    Life Sci; 2000 Dec; 68(2):233-9. PubMed ID: 11191640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
    Walentiny DM; Wiebelhaus JM; Beardsley PM
    Drug Alcohol Depend; 2018 Jun; 187():335-342. PubMed ID: 29705547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
    J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.
    Zaveri NT; Journigan VB; Polgar WE
    ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.